(MedPage Today) — Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort study suggested…
Football success did not drive decisions, says Spurs chief
Football success did not drive decisions, says Spurs chief Source: www.channelnewsasia.com






